explore -WSS

explore

author：knowledge 2025-09-06 04:41:35 - browse：8517

The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges.

The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Liver decline slowed by off

entertainment

WSS

PhRMA lawsuit over Medicare drug price negotiation tossed

Medicare threatens to cut off funding for HCA's Mission hospital

For longer

Why did Pfizer dish out millions for a Super Bowl ad?

What should King Charles tell the public about his cancer?

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

leisure time

explore

focus

As demand for Covid shots wanes, Moderna seeks its next success

Senators start work on Medicare physician payment reform

Jerome Adams on the need for new antivirals for Covid

Listen: More tumult at BIO & coercive care for sickle cell patients

Alkermes shareholders re

KalVista pill reduced swelling 'attacks' caused by genetic disease

Bright Health sells Medicare Advantage business to Molina

ASCO eve: Let’s set the table for this year's meeting

How one medical school became remarkably diverse

To avoid data mishandling cases, universities eye AI and other tools

focus

Senators start work on Medicare physician payment reform

Biden report: The neurospychology of memory and aging

As a primary care physician, here's how I hope to partner with AI

Gilead might be held responsible for not developing a drug

What should King Charles tell the public about his cancer?

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

entertainment

entertainment

hotspot

Wikipedia